As environmental and genetic components contribute to the PCOS expression, we compared levels of endocrine disruptors, steroid hormones, cytokines, and metabolic parameters in twenty healthy, nine normal-weight PCOS women, and ten obese PCOS women. Steroid hormones, bisphenols (BPA, BPS, BPF, BPAF) and parabens (methyl-, ethyl-, propyl-, butyl-, benzyl-parabens) were measured by liquid chromatography-tandem mass spectrometry. Differences between the groups were assessed using the Mann-Whitney U test. Spearman correlation coefficients were calculated for the individual parameters relationship. Significantly higher levels of BPA, anti-Müllerain hormone, lutropine, lutropine/folitropine ratio, testosterone, androstenedione, 7beta-OH-epiandrosterone, and cytokines (IL-6, VEGF, PDGF-bb), were found in normal-weight PCOS women compared to controls. Between normal-weight and obese PCOS women, there were no differences in hormonal, but in metabolic parameters. Obese PCOS women had significantly higher insulin resistance, fatty-liver index, triglycerides, cytokines (IL-2, IL-13, IFN-gamma). In healthy, but not in PCOS, women, there was a positive correlation of BPA with testosterone, SHBG with lutropine, and folitropine, while testosterone negatively correlated with SHBG. In obese women with PCOS, insulin resistance negatively correlated with SHBG and estradiol. No differences were observed in the paraben exposure. Levels of BPA were higher in PCOS women, indicating its role in the etiology. Obesity significantly worsens the symptoms.

Institute of Endocrinology Prague Czech Republic

Zobrazit více v PubMed

AKGUL S, SUR U, DUZCEKER Y, BALCI A, KIZILKAN MP, KANBUR N, BOZDAG G, ERKEKOGLU P, GUMUS E, KOCER-GUMUSEL B, DERMAN O. Bisphenol A and phthalate levels in adolescents with polycystic ovary syndrome. Gynecol Endocrinol. 2019;35:1084–1087. doi: 10.1080/09513590.2019.1630608. PubMed DOI

AKIN L, KENDIRCI M, NARIN F, KURTOGLUA S, SARAYMEN R, KONDOLOT M, KOCAK SO, HATIPOGLU N. Endocrine Disruptors and Polycystic Ovary Syndrome: Phthalates. Presented at ESPE 2014 in Dublin, Endocrine Abstracts; 2014a.p. P217.

AKIN L, NARINB F, KURTOGLUA S, SARAYMEN S, KONDOLOT M, KOCAK SO, HATIPOGLU N. The Role of Bisphenol A in Etiopathogenesis of Polycystic Ovary Syndrome in Adolescent Girls. Presented at ESPE 2014, Dublin. Endocrine Abstracts; 2014b.p. P-D-1-3-229.

AKIN L, KENDIRCI M, NARIN F, KURTOGLUA S, SARAYMEN R, KONDOLOT M, KOCAK S, ELMALI F. The endocrine disruptor bisphenol A may play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls. Acta Paediatr. 2015;104:e171–e177. doi: 10.1111/apa.12885. PubMed DOI

AMATO G, CONTE M, MAZZIOTTI G, LALLI E, VITOLO G, TUCKER AT, BELLASTELLA A, CARELLA CIZZO A. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol. 2003;101:1177–1182. doi: 10.1097/00006250-200306000-00009. PubMed DOI

ASUNCION M, CALVO RM, SAN MILLAN JL, SANCHO J, AVILA SESCOBAR-MORREALE HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434–2438. doi: 10.1210/jc.85.7.2434. PubMed DOI

AZZIZ R, WOODS KS, REYNA R, KEY TJ, KNOCHENHAUER E, SYILDIZ BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745–2749. doi: 10.1210/jc.2003-032046. PubMed DOI

AZZIZ R, CARMINA E, DEWAILLY D, DIAMANTI-KANDARAKIS E, ESCOBAR-MORREALE HF, FUTTERWEIT W, JANSSEN OE, LEGRO RS, NORMAN RJ, TAYLOR A, EWITCHEL SF. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237–4245. doi: 10.1210/jc.2006-0178. PubMed DOI

AZZOUZ A, RASCÓN AJ, BALLESTEROS E. Simultaneous determination of parabens, alkylphenols, phenylphenols, bisphenol A and triclosan in human urine, blood and breast milk by continuous solid-phase extraction and gas chromatography-mass spectrometry. J Pharm Biomed Anal. 2016;119:16–26. doi: 10.1016/j.jpba.2015.11.024. PubMed DOI

BAKER BH, WU H, LAUE HE, BOIVIN A, GILLET V, LANGLOIS MF, BELLENGER JP, BACCARELLI A, ATAKSER L. Methylparaben in meconium and risk of maternal thyroid dysfunction, adverse birth outcomes, and Attention-Deficit Hyperactivity Disorder (ADHD) Environ Int. 2020;139:105716. doi: 10.1016/j.envint.2020.105716. PubMed DOI PMC

BEDOGNI G, BELLENTANI S, MIGLIOLI L, MASUTTI F, PASSALACQUA M, CASTIGLIONE A, TIRIBELLI C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. doi: 10.1186/1471-230X-6-33. PubMed DOI PMC

BLEDZKA D, GROMADZINSKA J, WASOWICZ W. Parabens. From environmental studies to human health. Environ Int. 2014;67:27–42. doi: 10.1016/j.envint.2014.02.007. PubMed DOI

BURT SOLORZANO CM, BELLER JP, ABSHIRE MY, COLLINS JS, McCARTNEY C, RMARSHALL JC. Neuroendocrine dysfunction in polycystic ovary syndrome. Steroids. 2012;77:332–337. doi: 10.1016/j.steroids.2011.12.007. PubMed DOI PMC

CADAGAN D, KHAN RAMER S. Thecal cell sensitivity to luteinizing hormone and insulin in polycystic ovarian syndrome. Reprod Biol. 2016;16:53–60. doi: 10.1016/j.repbio.2015.12.006. PubMed DOI

CUNNINGHAM T, ALLGAR V, ATKIN S, KILPATRICK E, MAGUINESS S, SATHYAPALAN T. A prospective cohort study investigating endocrine disrupting agents and polycystic ovary syndrome within an IVF setting. Presented at Society for Endocrinology BES 2016 in Brighton, Endocrine Abstracts; p. P217. DOI

DARBRE PD. Endocrine disruption and human health. Academic Press; 2015.

DIAMANTI-KANDARAKIS E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med. 2008;10:e3. doi: 10.1017/S1462399408000598. PubMed DOI

DIAMANTI-KANDARAKIS E, PIPERI C. Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Hum Reprod Update. 2005;11:631–643. doi: 10.1093/humupd/dmi025. PubMed DOI

DIAMANTI-KANDARAKIS E, BOURGUIGNON J-P, GIUDICE LC, HAUSER R, PRINS GS, SOTO AM, ZOELLER R, TGORE AC. Endocrine-disrupting chemicals: an Endocrine Society Scientific Statement. Endocr Rev. 2009;30:293–342. doi: 10.1210/er.2009-0002. PubMed DOI PMC

DOMINGUEZ MA, PETRE MA, NEAL MS, FOSTER WG. Bisphenol A concentration-dependently increases human granulosa-lutein cell matrix metalloproteinase-9 (MMP-9) enzyme output. Reprod Toxicol. 2008;25:420–425. doi: 10.1016/j.reprotox.2008.05.059. PubMed DOI

DUNAIF A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774–800. doi: 10.1210/er.18.6.774. PubMed DOI

DUSKOVA M, KOLATOROVA L, STARKA L. Androgens in women - critical evaluation of the methods for their determination in diagnostics of endocrine disorders. Physiol Res. 2018;67(Suppl 3):S379–S390. doi: 10.33549/physiolres.933964. PubMed DOI

DUSKOVA M, KOLATOROVA L, SIMKOVA M, SRAMKOVA M, MALIKOVA M, HORACKOVA L, VITKU J, STARKA L. Steroid diagnostics of 21st century in the light of their new roles and analytical tools. Physiol Res. 2020;69(Suppl 2):S193–S203. doi: 10.33549/physiolres.934517. PubMed DOI PMC

EBEJER KCALLEJA-AGIUS J. The role of cytokines in polycystic ovarian syndrome. Gynecol Endocrinol. 2013;29:536–540. doi: 10.3109/09513590.2012.760195. PubMed DOI

EHRLICH S, CALAFAT AM, HUMBLET O, SMITH THAUSER R. Handling of thermal receipts as a source of exposure to bisphenol A. JAMA. 2014;311:859–860. doi: 10.1001/jama.2013.283735. PubMed DOI PMC

EHRMANN DA. Polycystic ovary syndrome. N Engl J Med. 2005;352:1223–1236. doi: 10.1056/NEJMra041536. PubMed DOI

ELADAK S, GRISIN T, MOISON D, GUERQUIN MJ, N’TUMBA-BYN T, POZZI-GAUDIN S, BENACHI A, LIVERA G, ROUILLER-FABRE VHABERT R. A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound. Fertil Steril. 2015;103:11–21. doi: 10.1016/j.fertnstert.2014.11.005. PubMed DOI

ELMALID F. In the role of bisphenol A in etiopathogenesis of polycystic ovary syndrome in adolescent girls. ESPE 2014, ESPE Abstracts. 2014

FENICHEL P, ROUGIER C, HIERONIMUS S, CHEVALIER N. Which origin for polycystic ovaries syndrome: Genetic, environmental or both? Ann Endocrinol (Paris) 2017;78:176–185. doi: 10.1016/j.ando.2017.04.024. PubMed DOI

FRANKS S. Polycystic ovary syndrome. N Engl J Med. 1995;333:853–861. doi: 10.1056/NEJM199509283331307. PubMed DOI

GONZÁLEZ F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77:300–305. doi: 10.1016/j.steroids.2011.12.003. PubMed DOI PMC

HORNUNG RW, REED LD. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg. 1990;5:46–51. doi: 10.1080/1047322X.1990.10389587. DOI

HOSSEIN RASHIDI B, AMANLOU M, BEHROUZI LAK T, GHAZIZADEH M, HAGHOLLAHI F, BAGHERI MESLAMI B. The association between bisphenol a and polycystic ovarian syndrome: a case-control study. Acta Med Iran. 2017;55:759–764. PubMed

HUGHESDON PE. Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called “hyperthecosis”. Obstet Gynecol Surv. 1982;37:59–77. doi: 10.1097/00006254-198202000-00001. PubMed DOI

KANDARAKI E, CHATZIGEORGIOU A, LIVADAS S, PALIOURA E, ECONOMOU F, KOUTSILIERIS M, PALIMERI S, PANIDIS DDIAMANTI-KANDARAKIS E. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab. 2011;96:E480–E484. doi: 10.1210/jc.2010-1658. PubMed DOI

KOLATOROVA L, SRAMKOVA M, VITKU J, VCELAK J, LISCHKOVA O, STARKA L, DUSKOVA M. Parabens and their relation to obesity. Physiol Res. 2018;67(Suppl 3):S465–S472. doi: 10.33549/physiolres.934004. PubMed DOI

KOLATOROVA SOSVOROVA L, CHLUPACOVA T, VITKU J, VLK M, HERACEK J, STARKA L, SAMAN D, SIMKOVA M, HAMPL R. Determination of selected bisphenols, parabens and estrogens in human plasma using LC-MS/MS. Talanta. 2017;174:21–28. doi: 10.1016/j.talanta.2017.05.070. PubMed DOI

KONIECZNA A, RACHON D, OWCZAREK K, KUBICA P, KOWALEWSKA A, KUDLAK B, WASIK ANAMIESNIK J. Serum bisphenol A concentrations correlate with serum testosterone levels in women with polycystic ovary syndrome. Reprod Toxicol. 2018;82:32–37. doi: 10.1016/j.reprotox.2018.09.006. PubMed DOI

La MARCA A, ORVIETO R, GIULINI S, JASONNI VM, VOLPE A, De LEO V. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertil Steril. 2004;82:970–972. doi: 10.1016/j.fertnstert.2004.06.001. PubMed DOI

LAVEN JS, MULDERS AG, VISSER JA, THEMMEN AP, De JONG FH, FAUSER BCJM. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004;89:318–323. doi: 10.1210/jc.2003-030932. PubMed DOI

LAZUROVA Z, FIGUROVA J, HUBKOVA B, LAZUROVA I. Relationship of urinary bisphenol A to metabolic and hormonal profile in PCOS women. Presented at 20th European Congress of Endocrinology, Endocrine Abstracts 56; 2018; DOI

LEGRO RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocrine Reviews. 2003;24:302–312. doi: 10.1210/er.2003-0004. PubMed DOI

LEGRO RS, KUNSELMAN AR, DODSON WC, DUNAIF A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84:165–169. doi: 10.1210/jcem.84.1.5393. PubMed DOI

MARTÍNEZ-REYES CP, GÓMEZ-ARAUZ AY, TORRES-CASTRO I, MANJARREZ-REYNA AN, PALOMERA LF, OLIVOS-GARCÍA A, MENDOZA-TENORIO E, SÁNCHEZ-MEDINA GA, ISLAS-ANDRADE S, MELENDEZ-MIER GESCOBEDO G. Serum levels of interleukin-13 increase in subjects with insulin resistance but do not correlate with markers of low-grade systemic inflammation. J Diabetes Res. 2018;2018:7209872. doi: 10.1155/2018/7209872. PubMed DOI PMC

MATTHEWS DR, HOSKER JP, RUDENSKI AS, NAYLOR BA, TREACHER DF, TURNER RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. doi: 10.1007/BF00280883. PubMed DOI

McCARTNEY CR, EAGLESON CA, MARSHALL JC. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome. Semin Reprod Med. 2002;20:317–326. doi: 10.1055/s-2002-36706. PubMed DOI

NELSON VL, QIN KN, ROSENFIELD RL, WOOD JR, PENNING TM, LEGRO RS, STRAUSS JF, 3RD, McALLISTER JM. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86:5925–5933. doi: 10.1210/jcem.86.12.8088. PubMed DOI

NIEMUTH NJ, KLAPER RD. Low-dose metformin exposure causes changes in expression of endocrine disruption-associated genes. Aquat Toxicol. 2018;195:33–40. doi: 10.1016/j.aquatox.2017.12.003. PubMed DOI

PALIOURA E, DIAMANTI-KANDARAKIS E. Industrial endocrine disruptors and polycystic ovary syndrome. J Endocrinol Invest. 2013;36:1105–1111. doi: 10.1007/BF03346762. PubMed DOI

PALIOURA E, DIAMANTI-KANDARAKIS E. Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs) Rev Endocr Metab Disord. 2015;16:365–371. doi: 10.1007/s11154-016-9326-7. PubMed DOI

PALIOURA E, KANDARAKI E, DIAMANTI-KANDARAKIS E. Endocrine disruptors and polycystic ovary syndrome: a focus on bisphenol A and its potential pathophysiological aspects. Horm Mol Biol Clin Investig. 2014;17:137–144. doi: 10.1515/hmbci-2014-0003. PubMed DOI

PATISAUL HB, MABREY N, ADEWALE HB, SULLIVAN AW. Soy but not bisphenol A (BPA) induces hallmarks of polycystic ovary syndrome (PCOS) and related metabolic co-morbidities in rats. Reprod Toxicol. 2014;49:209–218. doi: 10.1016/j.reprotox.2014.09.003. PubMed DOI PMC

PIGNY P, JONARD S, ROBERT Y, DEWAILLY D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:941–945. doi: 10.1210/jc.2005-2076. PubMed DOI

POLLACK AZ, MUMFORD SL, KRALL JR, CARMICHAEL A, ANDRIESSEN VC, KANNAN K, SCHISTERMAN EF. Urinary levels of environmental phenols and parabens and antioxidant enzyme activity in the blood of women. Environ Res. 2020;186:109507. doi: 10.1016/j.envres.2020.109507. PubMed DOI PMC

ROCHESTER JR, BOLDEN AL. Bisphenol S and F: a systematic review and comparison of the hormonal activity of bisphenol A substitutes. Environ Health Perspect. 2015;123:643–650. doi: 10.1289/ehp.1408989. PubMed DOI PMC

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25. doi: 10.1016/j.fertnstert.2003.10.004. PubMed DOI

RUTKOWSKA A, KONIECZNA A, WILCZEWSKA K, CIECHANOWICZ A, CZERNYCH R, RACHON D. The commonly used plasticisers (bisphenols and phthalates) as endocrine disrupting chemicals in healthy women and women with polycystic ovary syndrome. Presented at 17th European Congress of Endocrinology, Dublin 2015, Endocrine Abstracts; 2015; p. 37. DOI

SCHMIDT FM, WESCHENFELDER J, SANDER C, MINKWITZ J, THORMANN J, CHITTKA T, MERGL R, KIRKBY KC, FAßHAUER M, STUMVOLL M, HOLDT LM, TEUPSER D, HEGERL UHIMMERICH H. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One. 2015;10:e0121971–e0121971. doi: 10.1371/journal.pone.0121971. PubMed DOI PMC

SIMKOVA M, TICHY T, DUSKOVA M, BRADNA P. Dental composites - a low-dose source of bisphenol A? Physiol Res. 2020;69(Suppl 2):S295–S304. doi: 10.33549/physiolres.934518. PubMed DOI PMC

TAKEUCHI T, TTSUTSUMI O. Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels. Biochem Biophys Res Commun. 2002;291:76–78. doi: 10.1006/bbrc.2002.6407. PubMed DOI

TAKEUCHI T, TSUTSUMI O, IKEZUKI Y, TAKAI Y, TAKETANI Y. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J. 2004;51:165–169. doi: 10.1507/endocrj.51.165. PubMed DOI

VAGI SJ, AZZIZ-BAUMGARTNER E, SJODIN A, CALAFAT AM, DUMESIC D, GONZALEZ L, KATO K, SILVA MJ, YE XAZZIZ R. Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: a case-control study. BMC Endocr Disord. 2014;14:86. doi: 10.1186/1472-6823-14-86. PubMed DOI PMC

VAHEDI M, SAEEDI A, POORBAGHI SL, SEPEHRIMANESH M, FATTAHI M. Metabolic and endocrine effects of bisphenol A exposure in market seller women with polycystic ovary syndrome. Environ Sci Pollut Res Int. 2016;23:23546–23550. doi: 10.1007/s11356-016-7573-5. PubMed DOI

VELA-SORIA F, RODRÍGUEZ I, BALLESTEROS O, ZAFRA-GÓMEZ A, BALLESTEROS L, CELA RNAVALÓN A. Simplified matrix solid phase dispersion procedure for the determination of parabens and benzophenone-ultraviolet filters in human placental tissue samples. J Chromatogr A. 2014;1371:39–47. doi: 10.1016/j.chroma.2014.10.063. PubMed DOI

VERMEULEN A, VERDONCK L, KAUFMAN JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666–3672. doi: 10.1210/jcem.84.10.6079. PubMed DOI

VITKU J, CHLUPACOVA T, SOSVOROVA L, HAMPL R, HILL M, HERACEK J, BICIKOVA M, STARKA L. Development and validation of LC-MS/MS method for quantification of bisphenol A and estrogens in human plasma and seminal fluid. Talanta. 2015;140:62–67. doi: 10.1016/j.talanta.2015.03.013. PubMed DOI

VITKU J, KOLATOROVA L, FRANEKOVA L, BLAHOS J, SIMKOVA M, DUSKOVA M, SKODOVA T, STARKA L. Endocrine disruptors of the bisphenol and paraben families and bone metabolism. Physiol Res. 2018a;67(Suppl 3):S455–S464. doi: 10.33549/physiolres.934005. PubMed DOI

VITKU J, KOLATOROVA L, RICCO C, FERROUD C, HENNEBERT O, SKODOVA T, HERACEK J, STARKA L. The quantitation of 7beta-hydroxy-epiandrosterone in the plasma and seminal plasma of men with different degrees of fertility. Physiol Res. 2018b;67(Suppl 3):S511–S519. doi: 10.33549/physiolres.933963. PubMed DOI

WANG R, MOL BWJ. The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria? Hum Reprod. 2017;32:261–264. doi: 10.1093/humrep/dew287. PubMed DOI

WANG Y, ZHU Q, DANG X, HE Y, LI X, SUN Y. Local effect of bisphenol A on the estradiol synthesis of ovarian granulosa cells from PCOS. Gynecol Endocrinol. 2017;33:21–25. doi: 10.1080/09513590.2016.1184641. PubMed DOI

WEBBER LJ, STUBBS S, STARK J, TREW GH, MARGARA R, HARDY K, FRANKS S. Formation and early development of follicles in the polycystic ovary. Lancet. 2003;362:1017–1021. doi: 10.1016/S0140-6736(03)14410-8. PubMed DOI

WELSHONS WV, NAGEL SC, Vom SAAL FS. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology. 2006;147:S56–S69. doi: 10.1210/en.2005-1159. PubMed DOI

WIJEYARATNE CN, SENEVIRATNE R, De A, DAHANAYAKE S, KUMARAPELI V, PALIPANE E, KURUPPU N, YAPA C, SENEVIRATNE R, De A, BALEN AH. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic. Hum Reprod. 2011;26:202–213. doi: 10.1093/humrep/deq310. PubMed DOI

XIONG YL, LIANG XY, YANG X, LI Y, WEI LN. Low-grade chronic inflammation in the peripheral blood and ovaries of women with polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol. 2011;159:148–150. doi: 10.1016/j.ejogrb.2011.07.012. PubMed DOI

YANG Z, SHI J, GUO Z, CHEN M, WANG C, HE C, ZUO Z. A pilot study on polycystic ovarian syndrome caused by neonatal exposure to tributyltin and bisphenol A in rats. Chemosphere. 2019;231:151–160. doi: 10.1016/j.chemosphere.2019.05.129. PubMed DOI

ZAWADZKI J, DUNAIF A. Current issues in endocrinology and metabolism: polycystic ovary syndrome. Blackwell Scientific Publications; Cambridge, MA: 1992.

ZHOU W, FANG F, ZHU W, CHEN ZJ, DU Y, ZHANG J. Bisphenol A and ovarian reserve among infertile women with polycystic ovarian syndrome. Int J Environ Res Public Health. 2016;14:18. doi: 10.3390/ijerph14010018. PubMed DOI PMC

ŽALMANOVÁ T, HOŠKOVÁ K, NEVORAL J, PROKEŠOVÁ Š, ZÁMOSTNÁ K, KOTT T, PETR J. Bisphenol S instead of bisphenol A: a story of reproductive disruption by regretable substitution - a review. Czech J Anim Sci. 2016;61:433–449. doi: 10.17221/81/2015-CJAS. DOI

The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women

Androgens in SARS-CoV-2 coronavirus infections

Determination of Intraprostatic and Intratesticular Androgens